Skip to main content

Table 3 Effects of letrozole (Lz) pretreatment on plasma glucose levels in vehicle (V)- or insulin (INS)-injected male and female rats

From: Sex-dimorphic neuroestradiol regulation of ventromedial hypothalamic nucleus glucoregulatory transmitter and glycogen metabolism enzyme protein expression in the rat

Sex

Treatment groupse

V/Va

V/INSb

Lz/Vc

Lz/INSd

Male

174.5 ± 11.1

75.3 ± 4.1*

182.3 ± 8.9

72.8 ± 2.3*

Female

169.7 ± 5.9

60.3 ± 3.8*

148.2 ± 7.1***

79.5 ± 4.5**

  1. a Intracerebroventricular (icv) V infusion days 5–11; subcutaneous (sc) V injection day 11
  2. b icv V infusion days 5–11; sc neutral protamine Hagedorn insulin (INS; 10 U/kg bw) day 11
  3. c icv letrozole (Lz; 1.67 µg/µL dosage, 0.5 µL/h infusion rate) infusion days 5–11; sc V injection day 11
  4. d icv Lz infusion days 5–11; sc INS injection day 11
  5. e F(7/40) = 68.61; p < 0.0001
  6. * p < 0.0001 versus V-injected controls
  7. ** p < 0.005 versus V-injected controls
  8. *** p < 0.001 Lz/V-M versus Lz/V-F